Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol vs Risperidone vs Quetiapine for Delirium in Cancer Patients
IRCT20190404043159N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of haloperidol, risperidone and quetiapine in delirium and cancer (3 arms), sponsored by Isfahan University of Medical Sciences. Started Sep 2020; status: completed.
02
Drugs
haloperidolrisperidonequetiapine
03
Conditions
deliriumcancer
Beyond the preview
Go deeper on IRCT20190404043159N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190404043159N3.